ArticleJCI insight2021

Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa.

Dimitra Kiritsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.